medline.ch Gastroenterologie Leber Neoplasie

	Integrated Genetic Information of Metabolic Dysfunction-Associated Steatotic Liver Disease-Related Traits Improves Hepatocellular Carcinoma Risk Stratification and Screening. JCO Precis Oncol Du M, Wu T, Yuan H, Zhang T, Liu Z, Chen X. PMID: 41411614 [PubMed - indexed for MEDLINE]
	Efficacy and safety of Atezolizumab plus Bevacizumab and Lenvatinib as first-line systemic therapies for hepatocellular carcinoma: A real-world study. PLoS One Boonkaya S, Pattarawongpaiboon C, Thaimai P, Ananchuensook P, Sriphoosanaphan S, Tanasanvimon S, Teeyapun N, Pakvisal N, Siripon N, Treeprasertsuk S, Komolmit P, Thanapirom K. PMID: 41411278 [PubMed - indexed for MEDLINE]
	Dual-Contrast Agent Liver MRI for Liver Lesion Characterization. Radiographics Shetty AS, Ludwig DR, Fraum TJ, Lanier MH, Hoegger MJ, Rajput MZ, Tsai R. PMID: 41411165 [PubMed - indexed for MEDLINE]
	Spatial patterns and prognostic relevance of CD1a(+) immature and CD208(+) mature dendritic cells in colorectal cancer from non-tumor adjacent mucosa to liver metastases. Cancer Immunol Immunother Pavlov S, Ali E, Ye W, , Ambrozkiewicz F, Vy, Daum O, Li, Hemminki K, Trailin A. PMID: 41410751 [PubMed - indexed for MEDLINE]
	Case Report: Pseudoprogression of pancreatic acinar cell carcinoma after PD-1 blockade integrated treatment. Front Immunol Bai X, Yang D, Chen J, Liu Y, Tang H, Kong X, Liu B, Sha H, Du J. PMID: 41409298 [PubMed - indexed for MEDLINE]
	Myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) following atezolizumab and bevacizumab treatment for hepatocellular carcinoma. Neurol Sci Li YX, Wang RY, Hao YL. PMID: 41405648 [PubMed - indexed for MEDLINE]
	Prognostic Stratification of Initial Treatments for Hepatocellular Carcinoma Using a Modified Borderline Resectable Classification. Cancer Med Tada F, Hiraoka A, Ohama H, Saito M, Kimura Y, Nakamura A, Usui T, Kato K, Onishi K, Kitahata S, Kanemitsu-Okada K, Kawamura T, Kuroda T, Ishimura N, Hanaoka J, Watanabe J, Ohtani H, Miyake T, Yoshida O, Hirooka M, Miyata H, Tsubouchi E, Abe M, Ninomiya T, Hiasa Y. PMID: 41405376 [PubMed - indexed for MEDLINE]
	Facilitating Precision Medicine in HCC Patients by Deep Learning-Directed lncRNAs Classification and Ascertaining Causal Markers. J Gene Med Jain R, Mungamuri SK, Garg P. PMID: 41405166 [PubMed - indexed for MEDLINE]
	LASSO-empowered nomogram integrating nutritional-inflammatory-tumor characteristics predicts immunotherapy outcomes in advanced HCC: Large retrospective cohort. Front Immunol Hu S, Xu M, Li S, Chen W, Peng Z. PMID: 41403946 [PubMed - indexed for MEDLINE]
	Macrophage Polarization in the Tumor Microenvironment of Hepatocellular Carcinoma: From Mechanistic Insights to Translational Therapies. Cancer Control Fu X, Pang M, Wang Z, Wang H. PMID: 41403016 [PubMed - indexed for MEDLINE]
	Analysis of risk factors for early mortality following hepatectomy in hepatocellular carcinoma patients. BMC Surg Kou C, Zhu H, Fan L, Fan W, Cheung TT, Ji R. PMID: 41402783 [PubMed - indexed for MEDLINE]
	Burden and trends of NASH-related liver cancer associated with high fasting plasma glucose in China and globally from 1990 to 2021: a population-based analysis of the global burden of disease study. BMJ Open Yao Y, Ji C, Zhou C, Gui M. PMID: 41401990 [PubMed - indexed for MEDLINE]
	Efficacy and safety of percutaneous microwave ablation for liver tumors using an antenna with anti-phase technology offering ultraspherical ablation. Radiol Oncol Arik E, Taydas O, Dertli T, Sevinc OF, Kara AB, Topaloglu OF, Ozdemir M, Senturk A, Canturk AO, Hacibekiroglu I, Ozturk MH. PMID: 41401063 [PubMed - indexed for MEDLINE]
	Contrast-enhanced US Evaluation of Residual Hepatocellular Carcinoma Following Lenvatinib Combined with Anti-PD-1 Antibody Downstaging Therapy. Radiology Zhu L, Jiang B, Fei X, Xu Y, Liu Z, Zhang W, Liu B, Lu S, Luo Y. PMID: 41400470 [PubMed - indexed for MEDLINE]
	Real-World Efficacy of Transarterial Embolization and Transarterial Chemoembolization in Unresectable Hepatocellular Carcinoma: a Nationwide Cohort Study in Taiwan. Int J Med Sci Huang YH, Hu PJ, Chiu SH, Chang WC, Lin YF, Chang PY. PMID: 41399374 [PubMed - indexed for MEDLINE]
	Liver Transplantation for Combined Hepatocellular-Cholangiocarcinoma: A Retrospective Registry-Based Study Using the Korean Organ Transplant Registry (KOTRY). Ann Transplant Kim SH, Hwang S, Kim BW, Joo DJ, Lee KW, Choi GS, Ryu JH, Kim DS, Choi D, Cho JY, You YK, Choi D, Kim TS, Park P. PMID: 41399117 [PubMed - indexed for MEDLINE]
	Basic research on quercetin in liver cancer: Progress and perspectives. Medicine (Baltimore) Liu B, Yu Y, Wang R, Wu Y, Sun K. PMID: 41398772 [PubMed - indexed for MEDLINE]
	Prognostic and immunological implications of sialylation-associated gene signatures in hepatocellular carcinoma. Ann Med Wang GQ, Du K, Wang YP. PMID: 41398172 [PubMed - indexed for MEDLINE]
	The "silent assassin" of the liver: angiosarcoma with portal hypertension. Med Ultrason Zhang X, Qu N, Cao X. PMID: 41397175 [PubMed - indexed for MEDLINE]
	Concomitant medication use and clinical outcome in hepatocellular carcinoma treated with immune-based therapy: a multicenter analysis. Front Immunol Yi JZ, Xu J, Zeng JZ, Song YJ, Zhang YN, Huang CM, Li L, Ding K, Zhu ZJ, Yuan DZ, Fan YW, Ning SF, Liu X, Zhang JZ, You YF, Zhou Q, Song HJ, Tan GJ, Wu XT, Guo RP, Chen MS, Lyu N, Zhao M. PMID: 41394828 [PubMed - indexed for MEDLINE]

Artikel 1 - 20 / 74718

Seite 1 von 3736

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

Übersetzungsproblem?

mehr >>



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung